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background:  Patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) are at high-risk for thromboembolic 
and bleeding events. However, the influence of left ventricular dysfunction (LVD) on PCI outcomes and the post-procedural anti-thrombotic 
strategy in AF patients remains unknown.
methods:  The AVIATOR (Antithrombotic strategy Variability In Atrial fibrillation and Obstructive coronary disease Revascularized with 
PCI) Registry was a multicenter international registry including 859 patients with AF who underwent PCI between 2009 and 2011. LVD 
was defined as the presence of a left ventricular ejection fraction < 40%. Patients were stratified by treatment at discharge with either dual 
antiplatelet therapy (DAPT; aspirin plus clopidogrel) or triple therapy (TT; warfarin plus DAPT). The primary objective was to compare the 
incidence of major adverse cardiovascular and cerebrovascular events (MACCE) and bleeding (BARC ≥ 2) at 1-year of follow-up between 
LVD and non-LVD patients and between antithrombotic regimens in each group.
results:  Overall, 721 AF patients were included in the study cohort. Of these, 191/721 (26.4%) had LVD. As compared to non-LVD 
patients, those with LVD were more commonly males, had higher prevalence of previous myocardial infarction, lower glomerular filtration 
rate and higher CHADS2 score. Conversely, HAS-BLED score was similar between groups. Patients with LVD were more commonly 
discharged on TT (31.6% vs. 22%; p = 0.004). At 1 year of follow-up no differences in MACCE and in BARC ≥ 2 bleeding were observed 
between non-LVD and LVD patients. While bleeding rates were similar between TT and DAPT in patients with LVD (3.7% vs. 7.0%; p 
= 0.287), a higher incidence of BARC ≥ 2 bleeding occurred in patients with non-LVD under TT (6.9% vs. 3.3%; p = 0.042). Finally, no 
differences in MACCE rates at 1 year were observed between TT and DAPT in both groups.
Conclusion:  LVD in patients with AF was not associated with higher incidence of MACCE or bleeding following PCI. MACCE rates were 
similar between TT and DAPT in both LVD and non-LVD patients, while non-LVD patients under TT had a higher incidence of bleeding.
